BU — Burcon NutraScience Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$28.42m
- CA$33.07m
- CA$0.36m
2019 March 31st | C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -4.78 | -4.63 | -0.617 | -10.3 | -25.4 |
Depreciation | |||||
Non-Cash Items | 0.72 | 1.98 | -1.86 | 4.74 | 19.5 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.19 | -0.756 | -0.683 | -0.547 | -0.357 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -4.15 | -3.37 | -3.03 | -5.91 | -6.02 |
Capital Expenditures | -0.019 | -0.101 | -0.895 | -0.052 | -0.36 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | -14.4 | -1.82 | -1.18 | -4.07 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.019 | -14.5 | -2.72 | -1.23 | -4.43 |
Financing Cash Flow Items | -0.018 | -1.38 | -0.24 | 0 | -0.09 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.23 | 32.4 | 4.7 | 0.174 | 4.9 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -2.93 | 14.5 | -1.06 | -6.97 | -5.54 |